Kyntra Bio (KYNB) Financials: Revenue & Earnings

KYNB price $4.55 +0.05 +1.17%

Ticker
KYNB
Price
$4.55
Change
+0.05 +1.17%
Market cap ?
$18.43M
Beta ?
1.05
Sector
Healthcare
Industry
Biotechnology

Fair value

KYNB fair value $1,136.25. Price $4.55. Price is 100% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.83M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.10% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 4.05M. Net debt -47.87M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare KYNB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-3.55—1.77M
2026-08-132.96-3.18-1.50M2.09M
2026-05-11-3.74-3.363.70M1.55M
2026-03-16-3.51-3.891.30M1.67M
2025-11-10-1.61-4.011.08M2.43M
2025-08-11-3.38-2.251.30M2.63M
2025-05-120.050.752.70M1.60M
2025-03-17-4.50-2.003.14M24.90M
2024-11-12-4.25-7.6646.33M34.84M
2024-08-06-4.00-6.5050.64M34.66M
2024-05-06-8.25-7.7555.90M36.66M
2024-02-26-14.25-0.4227.14M38.90M
2023-11-06-13.00-17.0040.13M36.84M
2023-08-07-0.90-0.7044.32M34.73M
2023-05-08-0.81-0.7536.16M31.52M
2023-02-27-0.70-0.9434.37M23.97M
2022-11-07-0.98-0.8115.73M31.62M
2022-08-08-0.78-0.9429.81M36.16M
2022-05-09-0.68-0.8360.83M28.76M
2022-02-28-1.45-0.6616.54M47.65M
2021-11-090.542.25155.97M132.92M
2021-08-09-1.45-12.0024.36M69.07M
2021-05-10-0.78-22.5038.43M60.73M
2021-03-01-0.64-7.2565.00M100.81M
2020-11-050.36-22.2544.03M100.64M
2020-08-06-0.95-14.7542.89M28.89M
2020-05-07-0.89-7.5024.40M17.03M
2020-03-02-1.12-15.507.97M4.20M
2019-11-11-0.57-14.7533.17M32.01M
2019-08-081.34-12.25191.57M77.54M
2019-05-09-0.53-17.0023.86M30.17M
2019-02-270.250.50108.05M43.22M
2018-11-08-0.50-8.7529.03M19.74M
2018-08-07-0.28-14.5043.95M92.61M
2018-05-09-0.50-12.7531.93M32.56M
2018-02-27-0.27-7.0042.51M44.08M
2017-11-08-12.50-9.2527.27M—
2017-08-07-0.48-11.7529.00M28.39M
2017-05-09-0.52-0.4926.89M25.34M
2017-03-01-0.54-16.2531.91M31.32M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Singer Andrew E.Buy14.00K$6.5091.00K
2026-10-01Singer Andrew E.Other0——
2026-09-06Wettig ThaneSell209$8.551.79K
2026-09-06DeLucia DavidSell22$8.55188
2026-06-12Ho MaykinBuy7.00K$7.1349.91K
2026-06-12EDWARDS JEFFREY LBuy7.00K$7.1349.91K
2026-06-12Kauffman MichaelBuy7.00K$7.1349.91K
2026-06-12Schoeneck James ABuy7.00K$7.1349.91K
2026-06-06Wettig ThaneSell198$6.711.33K
2026-06-06DeLucia DavidSell52$6.71349
2026-05-14Wettig ThaneBuy2.80K$7.0919.85K
2026-05-14Wettig ThaneSell2.80K$7.0919.85K
2026-03-06Wettig ThaneSell277$6.841.89K
2026-03-06DeLucia DavidSell60$6.84410
2026-02-03Wettig ThaneBuy60.00K$8.50510.00K
2026-02-03DeLucia DavidBuy26.00K$8.50221.00K
2025-12-06DeLucia DavidSell52$8.42438
2025-12-06Wettig ThaneSell259$8.422.18K
2025-11-17Wettig ThaneBuy2.70K$9.1024.57K
2025-11-13Wettig ThaneBuy1.00K$9.189.18K
2025-09-06DeLucia DavidSell53$12.10641
2025-09-06Wettig ThaneSell248$12.103.00K
2025-06-30Schoeneck James ABuy23.57K$5.07119.48K
2025-06-06DeLucia DavidSell51$7.83399
2025-06-06Wettig ThaneSell246$7.831.93K
2025-06-04Ho MaykinBuy120.00K$0.3136.61K
2025-06-04EDWARDS JEFFREY LBuy120.00K$0.3136.61K
2025-06-04Schoeneck James ABuy120.00K$0.3136.61K
2025-06-04Kauffman MichaelBuy120.00K$0.3136.61K
2025-06-04Kauffman MichaelBuy70.00K$0.3121.36K
2025-06-04Kauffman MichaelOther0——
2025-03-24Wettig ThaneBuy145.00K$0.3550.66K
2025-03-21Schoeneck James ABuy50.00K$0.3417.04K
2025-03-20Schoeneck James ABuy250.00K$0.3588.00K
2025-03-06Wettig ThaneBuy781——
2025-03-06Wettig ThaneSell367$0.39143
2025-03-06Wettig ThaneSell22.04K$0.398.59K
2025-03-06Chung ChristineBuy781——
2025-03-06Chung ChristineSell422$0.39165
2025-03-06Chung ChristineSell7.01K$0.392.73K
2025-03-06DeLucia DavidSell2.33K$0.39907
2025-01-09DeLucia DavidBuy525.00K$0.65341.67K
2025-01-09Wettig ThaneBuy1.30M$0.65846.04K
2024-12-16DeLucia DavidOther0——
2024-12-16DeLucia DavidOther44.00K$1.8983.16K
2024-12-16DeLucia DavidOther13.60K$22.60307.36K
2024-12-16DeLucia DavidOther100.00K$1.21121.00K
2024-12-16DeLucia DavidOther41.10K$9.99410.59K
2024-12-07Graham JuanSell1.07K$0.34365
2024-12-06Graham JuanSell1.45K$0.34495
2024-12-06Wettig ThaneSell2.36K$0.34808
2024-12-06Chung ChristineSell2.79K$0.34955
2024-09-07Graham JuanSell1.06K$0.39415
2024-09-06Graham JuanSell16.05K$0.396.26K
2024-09-06Wettig ThaneSell2.36K$0.39922
2024-09-06Chung ChristineSell17.39K$0.396.78K
2024-08-01Wettig ThaneSell20.84K$0.479.79K
2024-06-22Wettig ThaneSell782$1.13884
2024-06-12Adib DeyaaBuy22.12K$1.1725.88K
2024-06-07Graham JuanSell1.18K$1.101.30K
2024-06-06Graham JuanSell17.80K$1.1921.18K
2024-06-06Chung ChristineSell19.29K$1.1922.95K
2024-06-06Wettig ThaneSell2.25K$1.192.68K
2024-06-05Schoeneck James ABuy70.00K$1.2184.70K
2024-06-05Lema GeraldBuy70.00K$1.2184.70K
2024-06-05Ho MaykinBuy70.00K$1.2184.70K
2024-06-05Cravatt BenjaminBuy70.00K$1.2184.70K
2024-06-05EDWARDS JEFFREY LBuy70.00K$1.2184.70K
2024-06-05Brennan AoifeBuy70.00K$1.2184.70K
2024-06-05Blaug SuzanneBuy70.00K$1.2184.70K
2024-05-01Wettig ThaneSell20.84K$1.1724.38K
2024-04-22Adib DeyaaSell0——
2024-04-22Adib DeyaaSell300.00K$1.71513.00K
2024-03-22Wettig ThaneSell782$2.582.02K
2024-03-07Wettig ThaneBuy50.00K$1.9195.47K
2024-03-07Graham JuanSell1.18K$1.792.11K
2024-03-06Graham JuanBuy781——
2024-03-06Graham JuanSell422$1.87789
2024-03-06Graham JuanSell20.33K$1.8738.01K
2024-03-06Wettig ThaneBuy781——
2024-03-06Wettig ThaneSell326$1.87610
2024-03-06Wettig ThaneSell4.21K$1.877.87K
2024-03-06Chung ChristineBuy781——
2024-03-06Chung ChristineSell422$1.87789
2024-03-06Chung ChristineSell23.17K$1.8743.32K
2024-02-21Wettig ThaneBuy834.00K$1.721.43M
2024-02-21Wettig ThaneBuy166.00K——
2024-02-21Chung ChristineBuy29.00K——
2024-02-21Chung ChristineBuy143.00K$1.72245.25K
2024-02-21Graham JuanBuy260.00K$1.72445.90K
2024-02-21Graham JuanBuy52.00K——
2024-02-01Wettig ThaneSell23.49K$2.3755.67K
2023-12-22Wettig ThaneSell819$0.76622
2023-12-07Graham JuanSell1.08K$0.62668
2023-12-06Graham JuanSell15.57K$0.589.03K
2023-12-06Chung ChristineSell18.18K$0.5810.55K
2023-12-06Wettig ThaneSell1.68K$0.58974
2023-11-01Wettig ThaneSell21.84K$0.5511.95K
2023-09-22Wettig ThaneSell819$0.79644
2023-09-07Graham JuanSell1.10K$0.991.09K

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

Kyntra Bio, Inc. (KYNB) trades at $4.55, with a market cap of $18.43M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Kyntra Bio (KYNB) Financials: Revenue & Earnings

KYNB$4.55+0.05 +1.17%

$18.43M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History